A Maieron

4.3k total citations
81 papers, 2.4k citations indexed

About

A Maieron is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, A Maieron has authored 81 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Hepatology, 45 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in A Maieron's work include Hepatitis C virus research (39 papers), Liver Disease Diagnosis and Treatment (37 papers) and Hepatitis B Virus Studies (17 papers). A Maieron is often cited by papers focused on Hepatitis C virus research (39 papers), Liver Disease Diagnosis and Treatment (37 papers) and Hepatitis B Virus Studies (17 papers). A Maieron collaborates with scholars based in Austria, Germany and United States. A Maieron's co-authors include Péter Ferenci, Rudolf Stauber, Christian Datz, Petra Steindl‐Munda, Harald Hofer, Wolfgang Vogel, Ivo Graziadei, Markus Peck‐Radosavljevic, Michael Straßer and Albert Friedrich Stättermayer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

A Maieron

72 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Maieron Austria 23 1.7k 1.4k 305 298 216 81 2.4k
Olivier Guillaud France 26 1.2k 0.7× 1.3k 0.9× 191 0.6× 614 2.1× 153 0.7× 100 2.3k
J. Ludwig United States 26 2.0k 1.2× 2.0k 1.4× 363 1.2× 1.0k 3.5× 87 0.4× 55 3.3k
Albert Friedrich Stättermayer Austria 27 1.6k 0.9× 1.6k 1.1× 369 1.2× 325 1.1× 231 1.1× 94 2.3k
Loreto Hierro Spain 28 1.7k 1.0× 1.5k 1.0× 218 0.7× 906 3.0× 141 0.7× 100 2.6k
Urmila Khettry United States 27 1.1k 0.6× 1.1k 0.8× 163 0.5× 1.1k 3.7× 34 0.2× 76 2.8k
Audrey Coilly France 23 1.4k 0.8× 1.4k 1.0× 117 0.4× 424 1.4× 23 0.1× 87 2.4k
Regino P. González‐Peralta United States 29 1.9k 1.1× 1.7k 1.2× 55 0.2× 294 1.0× 24 0.1× 90 2.5k
Jörg Jahnel Austria 15 369 0.2× 435 0.3× 165 0.5× 280 0.9× 86 0.4× 30 983
Katherine Stuart Australia 23 834 0.5× 859 0.6× 183 0.6× 253 0.8× 24 0.1× 73 1.6k
Gemino Fiorelli Italy 32 764 0.4× 1.1k 0.8× 585 1.9× 169 0.6× 42 0.2× 81 3.1k

Countries citing papers authored by A Maieron

Since Specialization
Citations

This map shows the geographic impact of A Maieron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Maieron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Maieron more than expected).

Fields of papers citing papers by A Maieron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Maieron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Maieron. The network helps show where A Maieron may publish in the future.

Co-authorship network of co-authors of A Maieron

This figure shows the co-authorship network connecting the top 25 collaborators of A Maieron. A scholar is included among the top collaborators of A Maieron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Maieron. A Maieron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Frey, Vanessa, Christian Datz, Patrick B. Langthaler, et al.. (2025). Association between depression and metabolic dysfunction-associated steatotic liver disease: a cross-sectional analysis from the paracelsus 10,000 Study. Hepatology International. 20(1). 59–68.
3.
4.
Maieron, A, et al.. (2025). The impact of artificial intelligence on the adenoma detection rate. Wiener klinische Wochenschrift. 138(1-2). 1–8.
5.
Brezina, Stefanie, Thilo Samson Chillon, A Maieron, et al.. (2025). Colorectal cancer mortality is associated with low selenoprotein P status at diagnosis. Redox Biology. 84. 103701–103701.
6.
Aigner, Elmar, Christian Datz, A Maieron, et al.. (2024). FRI-303 Depression as a determinant of metabolic dysfunction-associated steatotic liver disease (MASLD) risk in the Paracelsus 10, 000 study. Journal of Hepatology. 80. S500–S500.
7.
Ferlitsch, Monika, et al.. (2024). Areas of improvement for colorectal cancer screening: Results of a screening initiative for 10,000 health care employees in Austria. SHILAP Revista de lepidopterología. 12(11). E1425–E1433.
8.
Aigner, Elmar, Christian Datz, A Maieron, et al.. (2023). Relationships between education and non-alcoholic fatty liver disease. European Journal of Internal Medicine. 118. 98–107. 20 indexed citations
9.
Maieron, A, et al.. (2023). Felty’s syndrome. Frontiers in Medicine. 10. 1238405–1238405. 5 indexed citations
10.
11.
Pfisterer, Nikolaus, Caroline Schmidbauer, Florian Riedl, et al.. (2020). Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria. Wiener klinische Wochenschrift. 133(9-10). 421–431. 6 indexed citations
12.
Schwarzer, Rémy, Thomas Reiberger, Mattias Mandorfer, et al.. (2019). The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis. Journal of Gastroenterology. 55(5). 533–542. 20 indexed citations
13.
Flamm, Steven L., K. Rajender Reddy, Neddie Zadeikis, et al.. (2018). Efficacy and Pharmacokinetics of Glecaprevir and Pibrentasvir With Concurrent Use of Acid-Reducing Agents in Patients With Chronic HCV Infection. Clinical Gastroenterology and Hepatology. 17(3). 527–535.e6. 17 indexed citations
14.
Rutter, Karoline, Monika Ferlitsch, A Maieron, et al.. (2016). von Willebrand factor antigen (vWF-Ag): A non-invasive predictor of treatment response and serious adverse events in HCV patients with interferon triple therapy. Digestive and Liver Disease. 48(10). 1194–1199. 1 indexed citations
15.
Stättermayer, Albert Friedrich, Stefan Traussnigg, Hans‐Peter Dienes, et al.. (2015). Hepatic steatosis in Wilson disease – Role of copper and PNPLA3 mutations. Journal of Hepatology. 63(1). 156–163. 73 indexed citations
16.
Dieterich, Douglas T., Tarik Asselah, Dominique Guyader, et al.. (2014). SILEN-C3, a Phase 2 Randomized Trial with Faldaprevir plus Pegylated Interferon α-2a and Ribavirin in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients. Antimicrobial Agents and Chemotherapy. 58(6). 3429–3436. 9 indexed citations
17.
Pinter, Matthias, Florian Hucke, Ivo Graziadei, et al.. (2012). Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib. Radiology. 263(2). 590–599. 174 indexed citations
18.
Maieron, A, Sigrid Metz-Gercek, Thomas–Matthias Scherzer, et al.. (2011). Shortening of treatment duration in patients with chronic hepatitis C genotype 2 and 3 - impact of ribavirin dose - a randomized multicentre trial. BMC Research Notes. 4(1). 220–220. 1 indexed citations
19.
Ferenci, Peter, Hermann Laferl, Thomas–Matthias Scherzer, et al.. (2009). Peginterferon Alfa-2a/Ribavirin for 48 or 72 Weeks in Hepatitis C Genotypes 1 and 4 Patients With Slow Virologic Response. Gastroenterology. 138(2). 503–512.e1. 86 indexed citations
20.
Ferenci, Péter, Hermann Laferl, Thomas–Matthias Scherzer, et al.. (2008). Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response. Gastroenterology. 135(2). 451–458. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivier Guillaud Breakdown of academic impact, for papers by J. Ludwig Breakdown of academic impact, for papers by Albert Friedrich Stättermayer Breakdown of academic impact, for papers by Loreto Hierro Breakdown of academic impact, for papers by Urmila Khettry Breakdown of academic impact, for papers by Audrey Coilly Breakdown of academic impact, for papers by Regino P. González‐Peralta Breakdown of academic impact, for papers by Jörg Jahnel Breakdown of academic impact, for papers by Katherine Stuart Breakdown of academic impact, for papers by Gemino Fiorelli
Rankless by CCL
2026